Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-140928
Filing Date
2025-06-16
Accepted
2025-06-13 21:39:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d851714d424b5.htm 424B5 551252
2 GRAPHIC g851714g01a01.jpg GRAPHIC 43552
3 GRAPHIC g851714g08a00.jpg GRAPHIC 74325
  Complete submission text file 0001193125-25-140928.txt   711647
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Filer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-272909 | Film No.: 251048417
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)